Abstract:Motivation: Computational prediction of compound-protein interactions (CPIs) is of great importance for drug design and development, as genome-scale experimental validation of CPIs is not only time-consuming but also prohibitively expensive. With the availability of an increasing number of validated interactions, the performance of computational prediction approaches is severely impended by the lack of reliable negative CPI samples. A systematic method of screening reliable negative sample becomes critical to improving the performance of in silico prediction methods.Results: This article aims at building up a set of highly credible negative samples of CPIs via an in silico screening method. As most existing computational models assume that similar compounds are likely to interact with similar target proteins and achieve remarkable performance, it is rational to identify potential negative samples based on the converse negative proposition that the proteins dissimilar to every known/predicted target of a compound are not much likely to be targeted by the compound and vice versa. We integrated various resources, including chemical structures, chemical expression profiles and side effects of compounds, amino acid sequences, protein-protein interaction network and functional annotations of proteins, into a systematic screening framework. We first tested the screened negative samples on six classical classifiers, and all these classifiers achieved remarkably higher performance on our negative samples than on randomly generated negative samples for both human and Caenorhabditis elegans. We then verified the negative samples on three existing prediction models, including bipartite local model, Gaussian kernel profile and Bayesian matrix factorization, and found that the performances of these models are also significantly improved on the screened negative samples. Moreover, we validated the screened negative samples on a drug bioactivity dataset. Finally, we derived two sets of new interactions by training an support vector machine classifier on the positive interactions annotated in DrugBank and our screened negative interactions. The screened negative samples and the predicted interactions provide the research community with a useful resource for identifying new drug targets and a helpful supplement to the current curated compound-protein databases.

Topology-Driven Negative Sampling Enhances Generalizability in Protein-Protein Interaction Prediction

Deep Learning Frameworks for Protein–protein Interaction Prediction

Protein-protein Interaction Network with Machine Learning Models and Multiomics Data Reveal Potential Neurodegenerative Disease-Related Proteins

Prediction of Drug-Target Interactions with High-Quality Negative Samples and A Network-Based Deep Learning Framework

Effectiveness and efficiency: label-aware hierarchical subgraph learning for protein-protein interaction

HGNNPIP: A Hybrid Graph Neural Network framework for Protein-protein Interaction Prediction

Improving Compound-Protein Interaction Prediction by Building Up Highly Credible Negative Samples

Hierarchical graph learning for protein–protein interaction

Integrating Genomic Data and Topological Metrics to Obtain Reliable Protein-Protein Interactions

Efficient link prediction in the protein–protein interaction network using topological information in a generative adversarial network machine learning model

Local Network Topology in Human Protein Interaction Data Predicts Functional Association

Revisiting Drug-Protein Interaction Prediction: A Novel Global-Local Perspective

Hierarchical representation for PPI sites prediction

Prediction of Protein–Protein Interaction Sites with Machine-Learning-Based Data-Cleaning and Post-Filtering Procedures

Pitfalls of machine learning models for protein–protein interaction networks

Geometric de-noising of protein-protein interaction networks

Assessment of community efforts to advance network-based prediction of protein–protein interactions

Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?

A novel link prediction algorithm for reconstructing protein–protein interaction networks by topological similarity

PiNUI: A Dataset of Protein-Protein Interactions for Machine Learning

DSSGNN-PPI: A Protein-Protein Interactions prediction model based on Double Structure and Sequence graph neural networks